NCT00098800View on ClinicalTrials.gov

Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

November 30, 2006

Conditions
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
Interventions
DRUG

fenretinide

Trial Locations (1)

85724-5024

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arizona

OTHER

NCT00098800 - Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries | Biotech Hunter | Biotech Hunter